Iliades Theofilos, Printza Athanasia, Eleftheriades Nikolaos, Georgios Kekes, Psifidis Anestis, Thomas Zaramboukas
AHEPA Hospital, Medical School, Aristotelian University of Thessaloniki, Greece.
ORL J Otorhinolaryngol Relat Spec. 2002 Nov-Dec;64(6):454-6. doi: 10.1159/000067575.
Olfactory neuroblastoma is a rare malignant tumour, usually diagnosed at advanced stages. We studied 3 patients who were treated at our Institute between 1991 and 1999. One patient presented with a stage A and 2 with a stage B tumour. One patient presented with coma due to inappropriate secretion of antidiuretic hormone associated with a stage B tumour. All 3 patients were treated with complete surgical resection via a lateral rhinotomy approach and postoperative radiotherapy. There was no involvement of the cribriform plate. One patient developed a metachronous regional metastasis and was treated with neck dissection and radiotherapy. All 3 patients are free from recurrence with a follow-up period of 9 years, 18 months and 1 year, respectively. Combination therapy is the cornerstone of treatment for olfactory neuroblastoma. Complete surgical resection is the most important prognostic factor and can be accomplished via lateral rhinotomy for early stage tumours.
嗅神经母细胞瘤是一种罕见的恶性肿瘤,通常在晚期才被诊断出来。我们研究了1991年至1999年间在我院接受治疗的3例患者。1例患者为A期肿瘤,2例为B期肿瘤。1例B期肿瘤患者因抗利尿激素分泌不当出现昏迷。所有3例患者均通过鼻侧切开术进行了完整的手术切除,并接受了术后放疗。筛板未受累。1例患者出现异时性区域转移,接受了颈部清扫术和放疗。所有3例患者分别随访9年、18个月和1年,均无复发。联合治疗是嗅神经母细胞瘤治疗的基石。完整的手术切除是最重要的预后因素,对于早期肿瘤可通过鼻侧切开术完成。